Status: Not yet recruiting
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
The purpose of this study is to assess the safety and efficacy of CD19 UCAR-T cell therapy in Subjects with autoimmune diseases.
Participants needed: 24
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Institute of Hematology & Blood Diseases Hospital, ChinaUpdated: Dec 19, 2025Locations: 1
Eligibility criteria
Male or female, between 18 and 65 years old; [+2]
Patients with a history or concurrent diagnosis of active malignancies, includin... [+14]